Cefcapene pivoxil | Antibiotic/Gasdermin D inhibitor
Available Options
| Size: | Price | Quantity | |
|---|---|---|---|
| 20 mg | $35.00 | ||
| 100mg | $75.00 |
Cefcapene pivoxil (147816-24-8) is a pivalate ester prodrug form of the third generation cephalosporin Cefcapene. Displays broad-spectrum antibacterial activity against both Gram-negative and -positive bacteria including S. aureus.1 Cefcapene pivoxil potently suppresses gasdermin D-mediated pyroptosis via targeting of the oligomerization interface I.2 Active in vivo in a mouse model of sepsis. Cefcapene pivoxil acts synergistically with another gasdermin D inhibitor, SCR-1481B1 (Cat #10-3971), and a PD-L1 antibody to significantly enhance the antitumor activity of anti-PD-L1 therapy.
References/Citations:
- Ishikura et al. (1994), Synthesis and Structure-Activity Relationships of 7ß-[(Z)-2-(2-Aminothiazol-4-yl)-3-(Substituted)-2-Propenoylamino]-3-Cephems with C-3 Substitutions; J. Antibiotics. 47 466
- Hu et al. (2024), Identification of two repurposed drugs targeting GSDMD oligomerization interface I to block pyroptosis; Cell Chem. Biol. 31 P2024
C23H29N5O8S2·HCl·H2O
>98% HPLC
NMR: (Conforms)
Safety Data Sheet:
Product Data Sheet:
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee
Cefcapene pivoxil (147816-24-8) is a pivalate ester prodrug form of the third generation cephalosporin Cefcapene. Displays broad-spectrum antibacterial activity against both Gram-negative and -positive bacteria including S. aureus.1 Cefcapene pivoxil potently suppresses gasdermin D-mediated pyroptosis via targeting of the oligomerization interface I.2 Active in vivo in a mouse model of sepsis. Cefcapene pivoxil acts synergistically with another gasdermin D inhibitor, SCR-1481B1 (Cat #10-3971), and a PD-L1 antibody to significantly enhance the antitumor activity of anti-PD-L1 therapy.
References/Citations:
- Ishikura et al. (1994), Synthesis and Structure-Activity Relationships of 7ß-[(Z)-2-(2-Aminothiazol-4-yl)-3-(Substituted)-2-Propenoylamino]-3-Cephems with C-3 Substitutions; J. Antibiotics. 47 466
- Hu et al. (2024), Identification of two repurposed drugs targeting GSDMD oligomerization interface I to block pyroptosis; Cell Chem. Biol. 31 P2024
Calculate the molar concentration, mass or volume in a solution.
Concentration × Volume × Molecular Weight = Mass
